{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:43:30Z","timestamp":1780051410153,"version":"3.53.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.bbrc.2018.08.171","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T07:20:40Z","timestamp":1536132040000},"page":"447-453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Activin A induces leiomyoma cell proliferation, extracellular matrix (ECM) accumulation and myofibroblastic transformation of myometrial cells via p38 MAPK"],"prefix":"10.1016","volume":"504","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4921-570X","authenticated-orcid":false,"given":"Huiqiong","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas K.","family":"Sin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2018.08.171_bib1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijgo.2015.04.051","article-title":"Prevalence, morbidity, and current medical management of uterine leiomyomas","volume":"2","author":"Drayer","year":"2015","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.bbrc.2018.08.171_bib2","first-page":"211","article-title":"The estimated annual cost of uterine leiomyomata in the United States","volume":"3","author":"Cardozo","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.bbrc.2018.08.171_bib3","first-page":"955964","article-title":"Health care resource use for uterine fibroid tumors in the United States","volume":"4","author":"Flynn","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.bbrc.2018.08.171_bib4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(00)03622-9","article-title":"Uterine fibroids","volume":"357","author":"Stewart","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2018.08.171_bib5","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/j.fertnstert.2013.02.017","article-title":"Racial differences in fibroid prevalence and ultrasound findings in asymptomatic young women (18\u201330 years old): a pilot study","volume":"7","author":"Marsh","year":"2013","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.bbrc.2018.08.171_bib6","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/AOG.0000000000002309","article-title":"Change in surgical practice for women with leiomyomas after the U.S. Food and drug administration morcellator safety communication","volume":"5","author":"Clark","year":"2017","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.bbrc.2018.08.171_bib7","article-title":"Minimally invasive surgical techniques versus open myomectomy for uterine fibroids","volume":"21","author":"Bhave Chittawar","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbrc.2018.08.171_bib8","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.lpm.2013.02.325","article-title":"Management of myoma: what is the place for hysterectomy and how to perform it?","volume":"7\u20138","author":"Giraudet","year":"2013","journal-title":"Presse Med."},{"key":"10.1016\/j.bbrc.2018.08.171_bib9","article-title":"The impact of uterine leiomyomas: a national survey of affected women","volume":"4","author":"Borah","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.bbrc.2018.08.171_bib10","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/mnfr.201400134","article-title":"Use of dietary phytochemicals to target inflammation, fibrosis, proliferation, and angiogenesis in uterine tissues: promising options for prevention and treatment of uterine fibroids?","volume":"8","author":"Islam","year":"2014","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.bbrc.2018.08.171_bib11","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1177\/1933719114533728","article-title":"Uterine fibroids: clinical manifestations and contemporary management","volume":"21","author":"Doherty","year":"2014","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.bbrc.2018.08.171_bib12","article-title":"Aromatase inhibitors for uterine fibroids","volume":"10","author":"Song","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbrc.2018.08.171_bib13","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1210\/jc.2013-2623","article-title":"Role of Activin A and myostatin and their signaling pathway in human myometrial and leiomyoma cell function","volume":"5","author":"Islam","year":"2014","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2018.08.171_bib14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"2","author":"Wynn","year":"2008","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.bbrc.2018.08.171_bib15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3858\/emm.2012.44.4.024","article-title":"A\u00a0high concentration of genistein down-regulates Activin A, Smad3 and other TGF- \u03b2pathway genes in human uterine leiomyoma cells","volume":"4","author":"Di","year":"2012","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbrc.2018.08.171_bib16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00441-015-2324-3","article-title":"Possible involvement of inflammatory\/reparative processes in the development of uterine fibroids","volume":"2","author":"Protic","year":"2016","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bbrc.2018.08.171_bib17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/jcsm.12145","article-title":"Activin A induces skeletal muscle catabolism via p38\u03b2 mitogen-activated protein kinase","volume":"2","author":"Ding","year":"2017","journal-title":"J.\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.bbrc.2018.08.171_bib18","doi-asserted-by":"crossref","first-page":"24747","DOI":"10.1038\/srep24747","article-title":"Autophagy inhibition of hsa-miR-19a-3p\/19b-3p by targeting TGF-beta R II during TGF-beta1-induced fibrogenesis in human cardiac fibroblasts","volume":"6","author":"Zou","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2018.08.171_bib19","first-page":"1","article-title":"Adipose tissue-derived stem cells suppress hypertrophic scar fibrosis via the p38\/MAPK signaling pathway","volume":"1","author":"Li","year":"2016","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.bbrc.2018.08.171_bib20","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jep.2015.07.036","article-title":"Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK\/Akt pathways, compared to alpha-lipoic acid","volume":"173","author":"Mao","year":"2015","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.bbrc.2018.08.171_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.taap.2015.12.024","article-title":"Dioscin alleviates BDL- and DMN-induced hepatic fibrosis via Sirt1\/Nrf2-mediated inhibition of p38 MAPK pathway","volume":"8","author":"Gu","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bbrc.2018.08.171_bib22","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/01.LAB.0000017499.51216.3E","article-title":"Immortalization of human uterine leiomyoma and myometrial cell lines after induction of telomerase activity: molecular and phenotypic characteristics","volume":"6","author":"Carney","year":"2002","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbrc.2018.08.171_bib23","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1095\/biolreprod67.2.506","article-title":"Telomerase immortalization of human myometrial cells","volume":"2","author":"Condon","year":"2002","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.bbrc.2018.08.171_bib24","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1038\/emboj.2011.292","article-title":"C\/EBPb mediates tumour-induced ubiquitin ligase atrogin1\/MAFbx upregulation and muscle wasting","volume":"20","author":"Zhang","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2018.08.171_bib25","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1096\/fj.04-2364com","article-title":"TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1\/MAFbx in skeletal muscle","volume":"19","author":"Li","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrc.2018.08.171_bib26","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1210\/jc.2010-0501","article-title":"Activin A and myostatin response and steroid regulation in human myometrium: disruption of their signaling in uterine fibroid","volume":"3","author":"Ciarmela","year":"2011","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2018.08.171_bib27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2174\/1389203717666160322145731","article-title":"Biochemical pathways and myometrial cell differentiation leading to nodule formation containing collagen and fibronectin","volume":"2","author":"Feng","year":"2016","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.bbrc.2018.08.171_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1055\/s-0030-1251475","article-title":"Why leiomyomas are called fibroids: the central role of extracellular matrix in symptomatic women","volume":"3","author":"Malik","year":"2010","journal-title":"Semin. Reprod. Med."},{"key":"10.1016\/j.bbrc.2018.08.171_bib29","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0015-0282(00)00418-0","article-title":"Transforming growth factor-\u03b23 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation","volume":"5","author":"Arici","year":"2000","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.bbrc.2018.08.171_bib30","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nrrheum.2014.53","article-title":"Fibrosis-a lethal component of systemic sclerosis","volume":"7","author":"Ho","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bbrc.2018.08.171_bib31","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1242\/jcs.00059","article-title":"Fibronectin at a glance","volume":"20","author":"Pankov","year":"2002","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.bbrc.2018.08.171_bib32","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1083\/jcb.142.3.873","article-title":"The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-\u03b21","volume":"3","author":"Serini","year":"1998","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.bbrc.2018.08.171_bib33","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1210\/jc.2017-02295","article-title":"Matrix metalloproteinase activity correlates with uterine myoma volume reduction after ulipristal acetate treatment","volume":"4","author":"Courtoy","year":"2018","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2018.08.171_bib34","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.fertnstert.2014.10.038","article-title":"Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids","volume":"2","author":"Donnez","year":"2015","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.bbrc.2018.08.171_bib35","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"5","author":"Donnez","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2018.08.171_bib36","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus euprolide acetate for uterine fibroids","volume":"5","author":"Donnez","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2018.08.171_bib37","first-page":"596","article-title":"Loss of stiffness in collagen-rich uterine fibroids after digestion with purified collagenase Clostridium histolyticum","volume":"5","author":"Jayes","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.bbrc.2018.08.171_bib38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/humupd\/dmx032","article-title":"Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics","volume":"24","author":"Islam","year":"2018","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.bbrc.2018.08.171_bib39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/bcp.12063","article-title":"etal. Safety, tolerability, pharmacokinetics and pharmacodynamics of losmapimod following a single intravenous or oral dose in healthy volunteers","volume":"1","author":"Barbour","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bbrc.2018.08.171_bib40","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00228-015-1920-1","article-title":"Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects","volume":"10","author":"Singh","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18318655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18318655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,17]],"date-time":"2018-11-17T12:45:51Z","timestamp":1542458751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X18318655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0006291X18318655"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.08.171","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activin A induces leiomyoma cell proliferation, extracellular matrix (ECM) accumulation and myofibroblastic transformation of myometrial cells via p38 MAPK","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.08.171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}